|
|
|
|
|
by jvican
43 days ago
|
|
Much better than I originally expected. Drugs like kesimpta allow patients to self inject on a monthly basis relatively low doses, which limits side effects. Better than Ocrevus in that regard judging by what I’ve been hearing from fellow patients that have been using it for a while, even though equally effective. There has indeed been an insane amount of progress over the past years. I didn’t know about stem cell therapy as an alternative to MS treatment. |
|